Shahram Ghanaati1, Mike Barbeck, Ines Willershausen, Benjamin Thimm, Stefan Stuebinger, Tadas Korzinskas, Karina Obreja, Constantin Landes, Charles J Kirkpatrick, Robert A Sader. 1. Department for Oral, Cranio-Maxillofacial and Facial Plastic Surgery, Medical Center of the Goethe University Frankfurt, Frankfurt am Main, Germany; Institute of Pathology, REPAIR-Lab, University Medical Center, Johannes Gutenberg University Mainz, Germany; Institute for Dental Material Sciences and Technology, University Medical Center of the Johannes Gutenberg University Mainz, Germany; Institute for Biomechanics, ETH Zurich, Switzerland; Center for Applied Biotechnology and Molecular Medicine, Zurich, Switzerland.
Abstract
PURPOSE: In this study the de novo bone formation capacity of a nanocrystalline hydroxyapatite bone substitute was assessed 3 and 6 months after its insertion into the human sinus cavity. MATERIALS AND METHODS: Sinus cavity augmentation was performed in a total of 14 patients (n = 7 implantation after 3 months; n = 7 implantation after 6 months) with severely atrophic maxillary bone. The specimens obtained after 3 and 6 months were analyzed histologically and histomorphometrically with special focus on bone metabolism within the residual bone and the augmented region. RESULTS: This study revealed that bone tissue formation started from the bone-biomaterial-interface and was directed into the most cranial parts of the augmented region. There was no statistically significant difference in new bone formation after 3 and 6 months (24.89 ± 10.22% vs 31.29 ± 2.29%), respectively. CONCLUSIONS: Within the limits of the present study and according to previously published data, implant insertion in regions augmented with this bone substitute material could be considered already after 3 months. Further clinical studies with bone substitute materials are necessary to validate these findings.
PURPOSE: In this study the de novo bone formation capacity of a nanocrystalline hydroxyapatite bone substitute was assessed 3 and 6 months after its insertion into the human sinus cavity. MATERIALS AND METHODS: Sinus cavity augmentation was performed in a total of 14 patients (n = 7 implantation after 3 months; n = 7 implantation after 6 months) with severely atrophic maxillary bone. The specimens obtained after 3 and 6 months were analyzed histologically and histomorphometrically with special focus on bone metabolism within the residual bone and the augmented region. RESULTS: This study revealed that bone tissue formation started from the bone-biomaterial-interface and was directed into the most cranial parts of the augmented region. There was no statistically significant difference in new bone formation after 3 and 6 months (24.89 ± 10.22% vs 31.29 ± 2.29%), respectively. CONCLUSIONS: Within the limits of the present study and according to previously published data, implant insertion in regions augmented with this bone substitute material could be considered already after 3 months. Further clinical studies with bone substitute materials are necessary to validate these findings.
Authors: Eleni Kapogianni; Mike Barbeck; Tim Fienitz; Daniel Rothamel; Ole Jung; Aylin Arslan; Lennart Kuhnel; Xin Xiong; Rumen Krastev; Reinhard E. Friedrich; Reinhard Schnettler Journal: In Vivo Date: 2019 Nov-Dec Impact factor: 2.155
Authors: Jonas Lorenz; Alica Kubesch; Sarah Al-Maawi; Frank Schwarz; Robert A Sader; Markus Schlee; Shahram Ghanaati Journal: Clin Oral Investig Date: 2018-03-09 Impact factor: 3.573
Authors: Mike Barbeck; Tim Fienitz; Anne-Kathrin Jung; Ole Jung; Said Alkildani; Daniel Rothamel Journal: In Vivo Date: 2022 Sep-Oct Impact factor: 2.406
Authors: Hanna Pihlman; Pauli Keränen; Kaarlo Paakinaho; Jere Linden; Markus Hannula; Iida-Kaisa Manninen; Jari Hyttinen; Mikko Manninen; Outi Laitinen-Vapaavuori Journal: J Mater Sci Mater Med Date: 2018-10-08 Impact factor: 3.896
Authors: Shahram Ghanaati; Mike Barbeck; Jonas Lorenz; Stefan Stuebinger; Oliver Seitz; Constantin Landes; Adorján F Kovács; Charles J Kirkpatrick; Robert A Sader Journal: Ann Maxillofac Surg Date: 2013-07
Authors: Jonas Lorenz; Kathrin Eichler; Mike Barbeck; Henriette Lerner; Stefan Stübinger; Catherine Seipel; Thomas J Vogl; Adorján F Kovács; Shahram Ghanaati; Robert A Sader Journal: Ann Maxillofac Surg Date: 2016 Jul-Dec
Authors: Shahram Ghanaati; Samuel E Udeabor; Mike Barbeck; Ines Willershausen; Oliver Kuenzel; Robert A Sader; C James Kirkpatrick Journal: Head Face Med Date: 2013-01-04 Impact factor: 2.151